Alyeska Investment Group
TRIL

Alyeska Investment Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Alyeska Investment Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-22,378
Closed -$292K – 484
2015
Q3 		$292K Buy
22,378
+2,049
+10% +$26.7K ﹤0.01% 431
2015
Q2 		$444K Buy
+20,329
New +$444K 0.01% 433